P.J.H. Jongen

902 total citations
18 papers, 559 citations indexed

About

P.J.H. Jongen is a scholar working on Pathology and Forensic Medicine, Rheumatology and Neurology. According to data from OpenAlex, P.J.H. Jongen has authored 18 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 5 papers in Rheumatology and 4 papers in Neurology. Recurrent topics in P.J.H. Jongen's work include Multiple Sclerosis Research Studies (7 papers), Inflammatory Myopathies and Dermatomyositis (4 papers) and Peripheral Neuropathies and Disorders (3 papers). P.J.H. Jongen is often cited by papers focused on Multiple Sclerosis Research Studies (7 papers), Inflammatory Myopathies and Dermatomyositis (4 papers) and Peripheral Neuropathies and Disorders (3 papers). P.J.H. Jongen collaborates with scholars based in Netherlands, Switzerland and United States. P.J.H. Jongen's co-authors include W J van Venrooij, W.T.M. Vree Egberts, G.J.M. Pruijn, Saskia A. Rutjes, Bernard M.J. Uitdehaag, Anthony Traboulsee, Bettina Stubinski, Cris S. Constantinescu, Magnhild Sandberg‐Wollheim and John D. Pollard and has published in prestigious journals such as Neurology, Journal of Neurology Neurosurgery & Psychiatry and Physiology & Behavior.

In The Last Decade

P.J.H. Jongen

17 papers receiving 543 citations

Peers

Countries citing papers authored by P.J.H. Jongen

Since Specialization

Citations

This map shows the geographic impact of P.J.H. Jongen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.J.H. Jongen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.J.H. Jongen more than expected).

Fields of papers citing papers by P.J.H. Jongen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.J.H. Jongen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.J.H. Jongen. The network helps show where P.J.H. Jongen may publish in the future.

Co-authorship network of co-authors of P.J.H. Jongen

This figure shows the co-authorship network connecting the top 25 collaborators of P.J.H. Jongen. A scholar is included among the top collaborators of P.J.H. Jongen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.J.H. Jongen. P.J.H. Jongen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Poster Session 2 2018 ·Multiple Sclerosis Journal ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), M. Martens, P.J.H. Jongen	7
2	Improved Self-Efficacy in Persons with Relapsing Remitting Multiple Sclerosis after an Intensive Social Cognitive Wellness Program with Participation of Support Partners. 2014 ·Health and Quality of Life Outcomes ·P.J.H. Jongen, (unknown), Marco Heerings, (unknown), (unknown), (unknown), (unknown), (unknown), W.A.J.G. Lemmens, Rogier Donders, (unknown), Leo H. Visser	1
3	Monthly cycles of methylperdnisolone in combination with interferon beta-1a IM are efficacious in the treatment of early relapsing-remitting multiple sclerosis. The MECOMBIN study. 2009 ·Multiple Sclerosis Journal ·Mads Ravnborg, Per Soelberg Sørensen, Mats Andersson, Elisabeth Gulowsen Celius, P.J.H. Jongen, E Bartholomé, Irina Elovaara, (unknown), Cris S. Constantinescu	1
4	483 TREATMENT OF VOIDING DYSFUNCTION BY NEUROMODULATION IN A SELECTED MS PATIENT POPULATION 2009 ·European Urology Supplements ·(unknown), P.J.H. Jongen, John Heesakkers	0
5	Association between MRI parameters and the MS severity scale: a 12 year follow-up study 2009 ·Multiple Sclerosis Journal ·A. Minneboo, Bernard M.J. Uitdehaag, P.J.H. Jongen, Hugo Vrenken, (unknown), (unknown), CH Polman, (unknown), Frederik Barkhof	27
6	A Multi-Centre, Double Blind, Randomized, Placebo Controlled, Parallel Group Trial Investigating Methylprednisolone (MP) in Combination with Interferon-b-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) 2009 ·Radboud Repository (Radboud University) ·Mads Ravnborg, (unknown), Mats Andersson, Elisabeth Gulowsen Celius, P.J.H. Jongen, (unknown), Irina Elovaara, Karl T. Beer, Cris S. Constantinescu	2
7	Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS 2006 ·Neurology ·Ludwig Kappos, Anthony Traboulsee, Cris S. Constantinescu, Juha-Pekka Erälinna, (unknown), P.J.H. Jongen, John D. Pollard, Magnhild Sandberg‐Wollheim, Christian Sindic, Bettina Stubinski, Bernard M.J. Uitdehaag, (unknown)	198
8	Clinical and serological characteristics of 125 Dutch myositis patients 2002 ·Journal of Neurology ·G.J.D. Hengstman, R M Brouwer, W.T.M. Vree Egberts, H. P. Seelig, P.J.H. Jongen, W J van Venrooij, Baziel G.M. van Engelen	74
9	The FAS−670 polymorphism influences susceptibility to multiple sclerosis 2002 ·Journal of Neuroimmunology ·Tineke van Veen, Nynke F. Kalkers, J. Bart A. Crusius, (unknown), Frederik Barkhof, P.J.H. Jongen, A. S. Peña, Chris H. Polman, Bernard M.J. Uitdehaag	28
10	Isolation and identification of the C6-hydroxy and C20-hydroxy metabolites and glucuronide conjugate of methylprednisolone by preparative high-performance liquid chromatography from urine of patients receiving high-dose pulse therapy. 1999 ·Journal of Chromatography B ·T. B. Vree, A.J. Lagerwerf, (unknown), R. A. A. Maes, (unknown), C.P.W.G.M. Verwey-van Wissen, O. R. Hommes, P.J.H. Jongen	5
11	Isolation and identification of the C6-hydroxy and C20-hydroxy metabolites and glucuronide conjugate of methylprednisolone by preparative high-performance liquid chromatography from urine of patients receiving high-dose pulse therapy 1999 ·Journal of Chromatography B Biomedical Sciences and Applications ·T. B. Vree, C.P.W.G.M. Verwey-van Wissen, A.J. Lagerwerf, (unknown), R. A. A. Maes, (unknown), O.R. Hommes, P.J.H. Jongen	11
12	High-performance liquid chromatography analysis, preliminary pharmacokinetics, metabolism and renal excretion of methylprednisolone with its C6 and C20 hydroxy metabolites in multiple sclerosis patients receiving high-dose pulse therapy 1999 ·Journal of Chromatography B Biomedical Sciences and Applications ·Tom B. Vree, A.J. Lagerwerf, C.P.W.G.M. Verwey-van Wissen, P.J.H. Jongen	14
13	High-performance Liquid-chromatographic-Atmospheric-pressure Chemical-ionization Ion-trap Mass-spectrometric Identification of Isomeric C6-hydroxy and C20-hydroxy Metabolites of Methylprednisolone in the Urine of Patients Receiving High-dose Pulse Therapy 1999 ·Journal of Pharmacy and Pharmacology ·Tom B. Vree, (unknown), (unknown), Nico M. M. Nibbering, C.P.W.G.M. Verwey-van Wissen, A.J. Lagerwerf, R. A. A. Maes, P.J.H. Jongen	12
14	Cerebrospinal fluid analysis differentiates between relapsing-remitting and secondary progressive multiple sclerosis 1997 ·Journal of Neurology Neurosurgery & Psychiatry ·P.J.H. Jongen, (unknown), W.H. Doesburg, W.A.J.G. Lemmens, O. R. Hommes	17
15	Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy 1997 ·Clinical & Experimental Immunology ·Saskia A. Rutjes, W.T.M. Vree Egberts, P.J.H. Jongen, (unknown), G.J.M. Pruijn, W J van Venrooij	149
16	Predominant right leg dysfunction without asymmetric muscle inflammation in CD1 Swiss mice with coxsackievirus B1-induced myositis 1996 ·Physiology & Behavior ·P.J.H. Jongen	2
17	Inclusion body myositis responding to longterm chlorambucil treatment. 1995 ·PubMed ·P.J.H. Jongen, H. J. ter Laak, L.B.A. van de Putte	4
18	Coxsackie B1 virus-induced murine myositis: Relationship of disease severity to virus dose and antiviral antibody response 1994 ·Neuromuscular Disorders ·P.J.H. Jongen, F W Heessen, (unknown), J M Galama, F. Gabreëls	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact